Cargando…

Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform

The gold standard test available for detecting COVID–19 patients is Real Time RT–PCR. However, this method is expensive, needing special equipment and skilled laboratory staff. Recently, less expensive antigen tests have become available, that could easily and rapidly identify new COVID–19 cases. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Leventopoulos, Michail, Michou, Vassiliki, Papadimitropoulos, Miltiadis, Vourva, Evangelia, Manias, Nikolaos George, Kavvadas, Harilaos Panagiotis, Nikolopoulos, Dimitris, Tsilivakos, Vassilis, Georgoulias, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335347/
https://www.ncbi.nlm.nih.gov/pubmed/35998553
http://dx.doi.org/10.1016/j.diagmicrobio.2022.115786
_version_ 1784759318715826176
author Leventopoulos, Michail
Michou, Vassiliki
Papadimitropoulos, Miltiadis
Vourva, Evangelia
Manias, Nikolaos George
Kavvadas, Harilaos Panagiotis
Nikolopoulos, Dimitris
Tsilivakos, Vassilis
Georgoulias, Georgios
author_facet Leventopoulos, Michail
Michou, Vassiliki
Papadimitropoulos, Miltiadis
Vourva, Evangelia
Manias, Nikolaos George
Kavvadas, Harilaos Panagiotis
Nikolopoulos, Dimitris
Tsilivakos, Vassilis
Georgoulias, Georgios
author_sort Leventopoulos, Michail
collection PubMed
description The gold standard test available for detecting COVID–19 patients is Real Time RT–PCR. However, this method is expensive, needing special equipment and skilled laboratory staff. Recently, less expensive antigen tests have become available, that could easily and rapidly identify new COVID–19 cases. Our objective was to evaluate the Boson Rapid Antigen Test Card versus the RT–rtPCR, using samples taken both by laymen (self–testing) and professionals. The sensitivity, specificity and accuracy rates were, 98.18%, 100.00%, and 99.28%, respectively. The positive and negative predictive values were 100.00% and 98.82%, respectively. The detection rate for asymptomatic patients was 90.48%, and detection rate for Ct values ≥30 was 91.67%. Our results indicate a high coincidence rate between the Boson and the referencing RT–rtPCR method, meeting the performance standards recommended by the WHO. Therefore, this test could facilitate a fast self–testing screening method, for the detection of infected individuals.
format Online
Article
Text
id pubmed-9335347
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-93353472022-07-29 Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform Leventopoulos, Michail Michou, Vassiliki Papadimitropoulos, Miltiadis Vourva, Evangelia Manias, Nikolaos George Kavvadas, Harilaos Panagiotis Nikolopoulos, Dimitris Tsilivakos, Vassilis Georgoulias, Georgios Diagn Microbiol Infect Dis Article The gold standard test available for detecting COVID–19 patients is Real Time RT–PCR. However, this method is expensive, needing special equipment and skilled laboratory staff. Recently, less expensive antigen tests have become available, that could easily and rapidly identify new COVID–19 cases. Our objective was to evaluate the Boson Rapid Antigen Test Card versus the RT–rtPCR, using samples taken both by laymen (self–testing) and professionals. The sensitivity, specificity and accuracy rates were, 98.18%, 100.00%, and 99.28%, respectively. The positive and negative predictive values were 100.00% and 98.82%, respectively. The detection rate for asymptomatic patients was 90.48%, and detection rate for Ct values ≥30 was 91.67%. Our results indicate a high coincidence rate between the Boson and the referencing RT–rtPCR method, meeting the performance standards recommended by the WHO. Therefore, this test could facilitate a fast self–testing screening method, for the detection of infected individuals. The Authors. Published by Elsevier Inc. 2022-11 2022-07-29 /pmc/articles/PMC9335347/ /pubmed/35998553 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115786 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Leventopoulos, Michail
Michou, Vassiliki
Papadimitropoulos, Miltiadis
Vourva, Evangelia
Manias, Nikolaos George
Kavvadas, Harilaos Panagiotis
Nikolopoulos, Dimitris
Tsilivakos, Vassilis
Georgoulias, Georgios
Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform
title Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform
title_full Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform
title_fullStr Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform
title_full_unstemmed Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform
title_short Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform
title_sort evaluation of the boson rapid ag test vs rt–pcr for use as a self–testing platform
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335347/
https://www.ncbi.nlm.nih.gov/pubmed/35998553
http://dx.doi.org/10.1016/j.diagmicrobio.2022.115786
work_keys_str_mv AT leventopoulosmichail evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform
AT michouvassiliki evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform
AT papadimitropoulosmiltiadis evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform
AT vourvaevangelia evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform
AT maniasnikolaosgeorge evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform
AT kavvadasharilaospanagiotis evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform
AT nikolopoulosdimitris evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform
AT tsilivakosvassilis evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform
AT georgouliasgeorgios evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform